Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative analysis of cancer-associated fibroblast signature in gastric cancer. | Heliyon | 2023 | 37809716 | PubTator, text mining | PubMed |
| Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin. | Front Immunol | 2023 | 37809094 | PubTator, text mining | PubMed |
| Construction and application of adenoviral vectors. | Mol Ther Nucleic Acids | 2023 | 37808925 | PubTator, text mining | PubMed |
| Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients. | Medicine (Baltimore) | 2023 | 37800836 | PubTator, text mining | PubMed |
| Biomaterial-Mediated Genetic Reprogramming of Merkel Cell Carcinoma and Melanoma Leads to Targeted Cancer Cell Killing In Vitro and In Vivo. | ACS Biomater Sci Eng | 2023 | 37797944 | PubTator, text mining | PubMed |
| RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma. | PLoS One | 2023 | 37796823 | PubTator, text mining | PubMed |
| CD137L Inhibition Ameliorates Hippocampal Neuroinflammation and Behavioral Deficits in a Mouse Model of Sepsis-Associated Encephalopathy. | Neuromolecular Med | 2023 | 37796401 | PubTator, text mining | PubMed |
| ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1. | Cancer Immunol Immunother | 2023 | 37796298 | PubTator, text mining | PubMed |
| Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists. | Front Immunol | 2023 | 37795079 | PubTator, text mining | PubMed |
| Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies. | EMBO Mol Med | 2023 | 37782273 | PubTator, text mining | PubMed |
| A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer. | Sci Rep | 2023 | 37773310 | PubTator, text mining | PubMed |
| Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension. | ESC Heart Fail | 2023 | 37772417 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Reveals Peripheral T Helper Cells Promoting the Development of IgG4-Related Disease by Enhancing B Cell Activation and Differentiation. | Int J Mol Sci | 2023 | 37762039 | PubTator, text mining | PubMed |
| Bispecific Antibodies in Hematological Malignancies: A Scoping Review. | Cancers (Basel) | 2023 | 37760519 | PubTator, text mining | PubMed |
| Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes. | JCI Insight | 2023 | 37751304 | PubTator, text mining | PubMed |
| Elevated extracellular calcium ions accelerate the proliferation and migration of HepG2 cells and decrease cisplatin sensitivity. | J Biomed Res | 2023 | 37750331 | PubTator, text mining | PubMed |
| GBP5 Expression Predicted Prognosis of Immune Checkpoint Inhibitors in Small Cell Lung Cancer and Correlated with Tumor Immune Microenvironment. | J Inflamm Res | 2023 | 37750170 | PubTator, text mining | PubMed |
| Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we? | Cell Commun Signal | 2023 | 37749597 | PubTator, text mining | PubMed |
| Identification and validation of molecular subtypes and a 9-gene risk model for breast cancer. | Medicine (Baltimore) | 2023 | 37747033 | PubTator, text mining | PubMed |
| Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation. | EBioMedicine | 2023 | 37741009 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=16